Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESILIENT: Cerclage + Progesterone vs Progesterone Only for Preterm Birth Prevention
NCT06463652Recruiting
- Sponsor
- My Duc Hospital
- Start
- Jun 2024
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by My Duc Hospital. Primary endpoint: Time from randomization to delivery. Started Jun 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06463652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06463652.